Uncommon Features of Miller-Fisher Syndrome. Case Report and review of the literature

Main Article Content

Ruth Camila Púa Torrejón
Amanda Bermejo Gómez
Ana Gómez-Carpintero García
Rebeca Villares Alonso

Abstract

Background: Miller Fisher syndrome is an acute autoimmune polyneuropathy characterized by the clinical triad of areflexia, ataxia, and ophthalmoplegia. It is a rare pathology in the pediatric age that is associated, in most cases, with a history of an infectious process. In the cerebrospinal fluid analysis, cytological albumin dissociation and IgG antiganglioside antibodies against GQ1b stand out in more than 80% of cases. Case report: 5-year-old girl with the characteristic clinical triad, acute course, and history of gastrointestinal infection (no known infectious agent). Uncommon findings in the cerebrospinal fluid in this syndrome are described, such as leukocytosis and positivity for IgG antiganglioside antibodies against GT1a. The other antiganglioside antibodies were negative. The complementary tests are not helpful in confirming or ruling out the diagnosis since this is mainly clinical; however, they serve to rule out other pathologies included in the differential diagnosis. Conclusion: an early diagnosis is necessary to establish adequate support measures. Although immunoglobulins and plasmapheresis have been commonly used for their treatment, randomized clinical trials are needed to demonstrate their efficacy.


 

Downloads

Download data is not yet available.

Article Details

How to Cite
Púa Torrejón, R. C., Bermejo Gómez, A. ., Gómez-Carpintero García, A., & Villares Alonso, R. (2022). Uncommon Features of Miller-Fisher Syndrome. Case Report and review of the literature. Pediatría, 55(1), 30–35. https://doi.org/10.14295/rp.v55i1.264
Section
Review topics

References

Wakerley B, Uncini A, Yuki N. Guillain-Barré and Miller Fisher syndromes-new diagnostic classification. Nat. Rev.Neurol 2014; 10(9):537-44. DOI: https://doi.org/10.1038/nrneurol.2014.138

Ito M, Kuwabara S, Odaka M, Misawa S, Koga M, Hirata K, et al. Bickerstaff’s brainstem encephalitis and Fisher sindrome form a continuous spectrum. Clinical analysis of 581 cases. J Neurol 2008; 255:674-682. DOI: https://doi.org/10.1007/s00415-008-0775-0

Mori M, Kuwabara S, Fukutake T, Yuki N, Hattori T. Clinical features and prognosis of Miller Fisher sindrome. Neurology 2001; 56:1104-6. DOI: https://doi.org/10.1212/WNL.56.8.1104

Al Othman B, Raabe J, Kini A, Lee, A. Up to date: the Miller Fisher variants of Guillain-Barré syndrome. Curr Opin Ophthalmol 2019; 30(6):462-6. DOI: https://doi.org/10.1097/ICU.0000000000000611

Mori M, Kuwabara S, Fukutake T, Hattori T. Intravenous immunoglobulin therapy for Miller Fisher syndrome. Neurology2007; 68:1144–1146. DOI: https://doi.org/10.1212/01.wnl.0000258673.31824.61

Koga M, Kishi M, Fukusako T, Ikuta N, Kato M, Kanda T. Antecedent infection in Fisher syndrome: sources of variation in clinical characteristics. Journal of Neurology 2019; 266:1655- 1662. DOI: https://doi.org/10.1007/s00415-019-09308-x

Koga M, Gilbert M, Li J. Antecedent infections in Fisher syndrome: a common pathogenesis of molecular mimicry. Neurology 2005; 64:1605-11. DOI: https://doi.org/10.1212/01.WNL.0000160399.08456.7C

Reisin R, Salutto V, Aguirre F, Álvarez V, Barroso F, Bendersky M, et al. Utilidad de la identificación de anticuerpos en neuropatías periféricas, neuropatías y gangliopatías: revisión. NeurolArg 2020; 12(2): 98-112. DOI: https://doi.org/10.1016/j.neuarg.2020.01.004

A van Doorn P, Ruts L, Jacobs B. Clinical features, pathogenesis, and treatment of Guillain- Barré syndrome. Lancet Neurology 2008; 7(10):939-50. DOI: https://doi.org/10.1016/S1474-4422(08)70215-1

Kuitwaard K, de Gelder J, Tio‐Gillen A, Hop W, van Gelder T, van Toorenenbergen A, et al. Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barré syndrome. Ann. Neurol 2009; 66(5):597-603. DOI: https://doi.org/10.1002/ana.21737

Similar Articles

<< < 1 2 3 

You may also start an advanced similarity search for this article.